Evogene EVGN will release its quarterly earnings report on Thursday, 2024-11-21. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Evogene to report an earnings per share (EPS) of $-1.01.
The market awaits Evogene's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.14, leading to a 9.3% increase in the share price on the subsequent day.
Here's a look at Evogene's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -1.20 | -0.9 | -1.4 | -1.6 |
| EPS Actual | -1.06 | -0.8 | -1.3 | -0.8 |
| Price Change % | 9.0% | 14.000000000000002% | -3.0% | 1.0% |
Stock Performance
Shares of Evogene were trading at $1.725 as of November 19. Over the last 52-week period, shares are down 71.0%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Evogene visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
